Histogenics closed its previously-announced US $30.0MM private placement. Funds will support development of NeoCart® novel cartilage repair therapy, including completion of the ongoing Phase III clinical trial.
icotec launched the brand name of BlackArmor® for its Carbon/PEEK material, which has been used in spinal and fracture repair devices for 15 years in 20,000 implantations.Â